Bilaketaren emaitzak - Luca Mologni

Findu emaitzak
  1. 1
    Activity of second‐generation ALK inhibitors against crizotinib‐resistant mutants in an NPM‐ALK model compared to EML4‐ALK

    Activity of second‐generation ALK inhibitors against crizotinib‐resistant mutants in an NPM‐ALK model compared to EML4‐ALK nork Diletta Fontana, Monica Ceccon, Carlo Gambacorti‐Passerini, Luca Mologni

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors

    Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors nork Monica Ceccon, Luca Mologni, William H. Bisson, Léonardo Scapozza, Carlo Gambacorti‐Passerini

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases

    Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases nork Maurizio Gianni’, Isabella Ponzanelli, Luca Mologni, Uve Reichert, Alessandro Rambaldi, Mineko Terao, Enrico Garattini

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

    Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes nork Geeta G. Sharma, Inês Mota, Luca Mologni, Enrico Patrucco, Carlo Gambacorti‐Passerini, Roberto Chiarle

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK–Positive Anaplastic Large Cell Lymphoma

    Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK–Positive Anaplastic Large Cell Lymphoma nork Monica Ceccon, Luca Mologni, Giovanni De Giudici, Rocco Piazza, Alessandra Pirola, Diletta Fontana, Carlo Gambacorti‐Passerini

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

    In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor nork Philipp le Coutre, Luca Mologni, Loredana Cleris, Edoardo Marchesi, Elisabeth Buchdunger, Roberto Giardini, Franca Formelli, Carlo Gambacorti‐Passerini

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation

    Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation nork Addolorata Maria Luce Coluccia, Angelo Vacca, Mireia Duñach, Luca Mologni, Sara Redaelli, Victor Bustos, Daniela Benati, Lorenzo A. Pinna, Carlo Gambacorti‐Passerini

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting

    Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting nork Iván Plaza-Menacho, Luca Mologni, Elisa Sala, Carlo Gambacorti‐Passerini, Anthony I. Magee, Thera P. Links, Robert M.W. Hofstra, David Barford, Clare M. Isacke

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex

    Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex nork Rocco Piazza, Vera Magistroni, Angela Mogavero, Federica Andreoni, Chiara Ambrogio, Roberto Chiarle, Luca Mologni, Petra Bachmann, Richard B. Lock, Paola Collini, Giuseppe Pelosi, Carlo Gambacorti‐Passerini

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

    Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer nork Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta G. Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina, Rocco Piazza, Carlo Gambacorti‐Passerini, Luca Mologni

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism

    Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism nork Iván Plaza-Menacho, Andrea Morandi, Luca Mologni, Piet J. Boender, Carlo Gambacorti‐Passerini, Anthony I. Magee, Robert M.W. Hofstra, Phillip P. Knowles, Neil Q. McDonald, Clare M. Isacke

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase

    Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase nork Luca Mologni, Sébastien Tardy, Alfonso Zambon, Alexandre Orsato, William H. Bisson, Monica Ceccon, Michela Viltadi, Joseph D’Attoma, Sara Pannilunghi, Vito Vece, Jerome Bertho, Peter G. Goekjian, Léonardo Scapozza, Carlo Gambacorti‐Passerini

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome

    SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome nork Federica Banfi, Alicia Rubio, Mattia Zaghi, Luca Massimino, Giulia Fagnocchi, Edoardo Bellini, Mirko Luoni, Cinzia Cancellieri, Anna Bagliani, Chiara Di Resta, Camilla Maffezzini, Angelo Ianielli, Maurizio Ferrari, Rocco Piazza, Luca Mologni, Vania Broccoli, Alessandro Sessa

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Correction to “Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase”

    Correction to “Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase” nork Luca Mologni, Sébastien Tardy, Alfonso Zambon, Alexandre Orsato, Cédric Schneider, William H. Bisson, Monica Ceccon, Michela Viltadi, David Goyard, Pierre Garcia, Joseph D’Attoma, Sara Pannilunghi, Vito Vece, Jerome Bertho, David Gueyrard, Peter G. Goekjian, Léonardo Scapozza, Carlo Gambacorti‐Passerini

    Argitaratua 2022
    Testu osoa Testu osoa
    Errata/Corrigenda
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients

    Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase–Positive Lymphoma Patients nork Carlo Gambacorti‐Passerini, Francesca Farina, Alessandra Stasia, Sara Redaelli, Monica Ceccon, Luca Mologni, Cristina Messa, Luca Guerra, Giovanni De Giudici, Elena Sala, Lara Mussolin, Dries Deeren, Michael H. King, Michael Steurer, Rainer Ordemann, Amos Cohen, Matthias Grube, Léa Bernard, Gianpaolo Chiriano, Laura Antolini, Rocco Piazza

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma

    Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma nork Elif Karaca Atabay, Carmen Mecca, Qi Wang, Chiara Ambrogio, Inês Mota, Nina Prokoph, Giulia Mura, Cinzia Martinengo, Enrico Patrucco, Giulia C. Leonardi, Jessica Hossa, Achille Pich, Luca Mologni, Carlo Gambacorti‐Passerini, Laurence Brugières, Birgit Geoerger, Suzanne D. Turner, Claudia Voena, Taek-Chin Cheong, Roberto Chiarle

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency

    Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency nork Monica Ceccon, Maria Elena Boggio Merlo, Luca Mologni, Teresa Poggio, Lydia M. Varesio, Matteo Menotti, Silvia Bombelli, R Rigolio, Andrea D. Manazza, Filomena Di Giacomo, Chiara Ambrogio, Giovanni De Giudici, Chiara Casati, Cristina Mastini, Mara Compagno, Suzanne D. Turner, Carlo Gambacorti‐Passerini, Roberto Chiarle, Claudia Voena

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

    STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma nork Cosimo Lobello, Boris Tichý, Vojtěch Bystrý, Lenka Radová, Daniel Filip, Marek Mráz, Ivonne A. Montes‐Mojarro, Nina Prokoph, Hugo Larose, Huan-Chang Liang, Geeta G. Sharma, Luca Mologni, David Belada, Kateřina Kamarádová, Falko Fend, Carlo Gambacorti‐Passerini, Olaf Merkel, Suzanne D. Turner, Andrea Janíková, Šárka Pospı́šilová

    Argitaratua 2020
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Efficacy of a Cancer Vaccine against <i>ALK</i>-Rearranged Lung Tumors

    Efficacy of a Cancer Vaccine against <i>ALK</i>-Rearranged Lung Tumors nork Claudia Voena, Matteo Menotti, Cristina Mastini, Filomena Di Giacomo, Dario Livio Longo, Barbara Castella, Maria Elena Boggio Merlo, Chiara Ambrogio, Qi Wang, Valerio Giacomo Minero, Teresa Poggio, Cinzia Martinengo, Lucia D’Amico, Elena Panizza, Luca Mologni, Federica Cavallo, Fiorella Altruda, Mohit Butaney, Marzia Capelletti, Giorgio Inghirami, Pasi A. Jänne, Roberto Chiarle

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

    Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications nork Elena Ardini, Maria Menichincheri, Patrizia Banfi, Roberta Bosotti, Cristina Ponti, Romana Pulci, Dario Ballinari, Marina Ciomei, Gemma Texidó, Anna Degrassi, Nilla Avanzi, Nadia Amboldi, Maria Beatrice Saccardo, Daniele Casero, Paolo Orsini, Tiziano Bandiera, Luca Mologni, David W. Anderson, Wei Ge, Jason Harris, Jean‐Michel Vernier, Gang Li, Eduard Felder, Daniele Donati, Antonella Isacchi, Enrico Pesenti, Paola Magnaghi, Arturo Galvani

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: